Abstract

<title>Abstract</title> Immune-checkpoint inhibitors (ICIs) are the primary treatment for advanced cutaneous squamous cell carcinoma (cSCC). Tumour microenvironment differences between immunocompetent and immunocompromised patients may underpin the development of effective biomarkers. Across 4 cSCC patients, we profiled 190 consecutively gridded, pathology assigned, regions of interest, using the GeoMx Discovery Protein Atlas (1116 protein markers). Expression profiles underscored by metabolic and immunological activity, including type I interferon signalling, differentiate patient immune competency.

Affiliated Institutions

Related Publications

Publication Info

Year
2025
Type
article
Citations
0
Access
Closed

External Links

Download PDF (Free) View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

0
OpenAlex
0
CrossRef

Cite This

Rahul Ladwa, Meg L. Donovan, Naomi Berrell et al. (2025). Resolving tissue-level proteomic complexity in cutaneous squamous cell carcinoma (cSCC) with ultra high-plex spatial profiling. . https://doi.org/10.21203/rs.3.rs-8245885/v1

Identifiers

DOI
10.21203/rs.3.rs-8245885/v1

Data Quality

Data completeness: 70%